Wyss Institute affected by Trump’s Harvard funds freeze
April 17, 2025
Harvard’s Wyss Institute — a top medtech research institute in the U.S. — has received Stop Work Orders on three government contracts.
Harvard’s Wyss Institute — a top medtech research institute in the U.S. — has received Stop Work Orders on three government contracts.
TEL AVIV, Israel, April 17, 2025 /PRNewswire/ — Sanoculis Ltd., a company specializing in ophthalmic medical device technologies, today announced that it has received CE Mark approval under the Medical Device Regulation (MDR) in the European Union (EU) for its MINT® (Minimally Invasive Nasal Trabeculostomy) product—an innovative, stent-free technology platform for the treatment of adult patients undergoing glaucoma angle surgery.
Scientists from the University of Bristol and the UK Atomic Energy Authority (UKAEA) have developed the world’s first carbon-14 diamond battery, capable of providing power for thousands of years.
Discover the groundbreaking Betavolt atomic battery, redefining energy with a 50-year charge cycle.
FREMONT, Calif., April 16, 2025 /PRNewswire/ — THINK Surgical, Inc., an innovator in the field of orthopedic surgical robots, today announced the successful first use of Maxx Orthopedics’ Freedom Total Knee implant utilizing the TMINI® Miniature Robotic System by Dr. David V. Cashen, a Joint Replacement specialist at Coastal Orthopedics Surgery Center in Bradenton, Florida.
DUBLIN, April 16, 2025 /PRNewswire/ — LUMA Vision Ltd., an innovative leader in advanced cardiac imaging and navigation, today announced the FDA clearance of its VERAFEYE™ Visualization Platform. This novel catheter-based imaging system provides real-time, two and four-dimensional, 360-degree visualization, significantly enhancing clinician precision and confidence during complex electrophysiology and structural heart procedures. The system is prepared for magnetic tracking and navigation of third-party catheters, which in the future, will further empower clinicians to perform complex procedures with greater precision and control.
PHILADELPHIA, April 15, 2025 /PRNewswire/ — ActiveProtective® (APT) is proud to announce the launch of Tango® Belt, a wearable medical device utilizing sensors to monitor motion and deploy airbags during serious hip-impacting falls. The Tango Belt, having already received Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA), was further granted marketing authorization as a prescription-only device intended as an adjunctive to standard-of-care to reduce the risk of hip fracture or hip dislocation due to falls in older adults at risk of major hip injury due to falls (DEN240021).
Researchers have developed a cutting-edge chip technology capable of precisely mimicking the interactions between cancer cells and blood vessels, akin to the human body environment. This innovation is being hailed as a significant breakthrough in the quest for patient-specific cancer drug development.
The replacement system is launching into markets already served by repair devices, namely Edwards’ Pascal and Abbott’s Mitraclip.
CeriBell (Nasdaq:CBLL) announced today that it received FDA 510(k) clearance for its next-generation Ceribell Clarity algorithm.